Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-19-017559
Filing Date
2019-04-02
Accepted
2019-04-02 06:05:32
Documents
80
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tv517858_10ka.htm 10-K/A 977817
2 EXHIBIT 23.1 tv517858_ex23-1.htm EX-23.1 2522
3 EXHIBIT 31.1 tv517858_ex31-1.htm EX-31.1 9187
4 EXHIBIT 32.1 tv517858_ex32-1.htm EX-32.1 3930
11 GRAPHIC tv517858_img01.jpg GRAPHIC 46805
  Complete submission text file 0001144204-19-017559.txt   9561626

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ttnp-20181231.xml EX-101.INS 3014599
6 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20181231.xsd EX-101.SCH 60040
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20181231_cal.xml EX-101.CAL 43731
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20181231_def.xml EX-101.DEF 369879
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20181231_lab.xml EX-101.LAB 418186
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20181231_pre.xml EX-101.PRE 433642
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-13341 | Film No.: 19722699
SIC: 2836 Biological Products, (No Diagnostic Substances)